Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Centogene N.V. (CNTG)

Centogene N.V. (CNTG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 200,398
  • Shares Outstanding, K 19,861
  • Annual Sales, $ 146,650 K
  • Annual Income, $ -24,490 K
  • 60-Month Beta -2.15
  • Price/Sales 1.39
  • Price/Cash Flow N/A
  • Price/Book 2.75
Trade CNTG with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.35
  • Number of Estimates 1
  • High Estimate -0.35
  • Low Estimate -0.35
  • Prior Year -0.32
  • Growth Rate Est. (year over year) -9.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.54 +3.98%
on 09/20/21
11.07 -10.39%
on 09/07/21
-0.39 (-3.78%)
since 08/20/21
3-Month
9.54 +3.98%
on 09/20/21
11.95 -16.99%
on 07/09/21
+0.06 (+0.61%)
since 06/18/21
52-Week
8.61 +15.18%
on 05/11/21
14.79 -32.93%
on 10/20/20
-1.41 (-12.44%)
since 09/18/20

Most Recent Stories

More News
New Strong Sell Stocks for September 10th

CNTG, JOAN, STRT, ZNGA, and PTVE have been added to the Zacks Rank #5 (Strong Sell) List on September 10, 2021

ZNGA : 7.74 (-3.37%)
STRT : 36.51 (-3.85%)
CNTG : 9.92 (-1.68%)
PTVE : 11.00 (+0.55%)
JOAN : 11.61 (-2.76%)
Centogene N.V. (CNTG) Reports Q2 Loss, Tops Revenue Estimates

Centogene N.V. (CNTG) delivered earnings and revenue surprises of -73.08% and 62.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CNTG : 9.92 (-1.68%)
Centogene N.V. (CNTG) Stock Jumps 7.5%: Will It Continue to Soar?

Centogene N.V. (CNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

CNTG : 9.92 (-1.68%)
Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner

Zacks Industry Outlook Highlights: Computer Programs and Systems, Centogene and Cerner

CERN : 73.69 (-1.80%)
CPSI : 34.42 (-3.75%)
CNTG : 9.92 (-1.68%)
CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal Dementia

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced a new observational study to understand...

CNTG : 9.92 (-1.68%)
ALEC : 25.77 (-3.88%)
STERIS (STE) to Report Q4 Earnings: What's in the Cards?

STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.

COO : 429.90 (-1.53%)
STE : 212.52 (-1.19%)
BWAY : 7.81 (-2.38%)
CNTG : 9.92 (-1.68%)
Centogene (CNTG) Enters Oversold Territory

Centogene (CNTG) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

CNTG : 9.92 (-1.68%)
4 Medical Products Stocks Set to Beat This Earnings Season

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

XRAY : 59.65 (-2.58%)
OMI : 33.50 (-2.62%)
HOLX : 76.73 (-1.16%)
BSX : 43.64 (-1.65%)
LH : 293.91 (-0.68%)
INGN : 46.42 (-5.75%)
CNTG : 9.92 (-1.68%)
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical...

CNTG : 9.92 (-1.68%)
PFE : 44.20 (+0.71%)
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 169.91 (-2.13%)
CNCR : 30.70 (-0.57%)
BBH : 213.73 (-1.92%)
ARKG : 80.33 (-4.29%)
AYTU : 3.00 (-4.15%)
FTSV : 95.51 (+0.05%)
VIR : 49.70 (-8.87%)
IDNA : 53.54 (-3.01%)
CODX : 9.53 (-4.89%)
CNTG : 9.92 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company's goal is to bring rationality to treatment decisions and to accelerate the development...

See More

Key Turning Points

3rd Resistance Point 10.91
2nd Resistance Point 10.56
1st Resistance Point 10.24
Last Price 9.92
1st Support Level 9.57
2nd Support Level 9.22
3rd Support Level 8.90

See More

52-Week High 14.79
Fibonacci 61.8% 12.43
Fibonacci 50% 11.70
Fibonacci 38.2% 10.97
Last Price 9.92
52-Week Low 8.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar